Biosimilars, as always, are a hot topic in the pharmaceutical space as many blockbuster drugs go off patent and pharmaceutical companies scrambling to develop and register follow on biologics. The World Biosimilar Congress 2012 brought together senior level executives and opinion leaders from around the globe to further their knowledge and engage in discussion on a variety of topics relating to biosimilar development, production and regulations. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Michael Cohen, Managing Director, Myoderm, âChallenges of sourcing comparators for biosimilar research and trials'.
This presentation focuses on:
Â· Outlining the challenges that exist at every phase of research
Â· Understanding the differences in sourcing from US and EU markets
Â· Understanding the challenges for specific products both present and future
Are you interested in learning more about biosimilars? Then you might be interested in attending the World Biosimilar Congress 2013. This event is set to discuss the global biosimilar development landscape, regulations, process development, clinical trial considerations, pharmacovigilence and a host of other topics.Â Myoderm is a Gold Sponsor of the 2013 event, and we're looking forward to Michael Cohen sharing his expertise with the delegation once again.
Want more from Total BioPharma? Sign up to our newsletter – it doesn't cost anything and only takes a minute.